FIELD: organic chemistry, pharmacy. SUBSTANCE: invention proposes 3-[2-(dimethylamino)-ethyl] -N-methyl-1H-indole-5-meth- -ane sulfoneamide sulfate salt (2:1) used for preparing pharmaceutical compositions, in part, for intranasal agents, for treatment of states associated with headache, in part, migraine. EFFECT: improved method of synthesis, enhanced effectiveness of treatment. 14 cl, 7 tbl
Authors
Dates
1998-04-10—Published
1991-12-10—Filed